skip to Main Content
Robert C. Wolcott

Robert C. Wolcott

Chair & Co-Founder at TWIN Global

Prof. Wolcott is Adjunct Professor of Innovation at the Booth School of Business, University of Chicago, and Adjunct Professor of Executive Education at the Kellogg School of Management, Northwestern University. He’s co-founder and chair of The World Innovation Network (TWIN), a global community of nearly 4,000 innovation and growth leaders from over 30 countries and across sectors. He is a regular contributor for Forbes on the impact of technology on business, society and humanity. Wolcott’s work appears in MIT Sloan Management Review, strategy + business, The Harvard Business Review (online), The Wall Street Journal, Advertising Age, Business Week, The Financial Times (European Edition), The New York Times and numerous overseas publications.

14:30 - 15:30

Parallel sessions

Academia session: Biotechnology - How is it shaping our future?

Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor

  • Dr. Charles Ruranga, Director of the African Centre of Excellence in Data Science, Rwanda 
  • Dr. Claudia Vickers, Chief Scientific Officer at Eden Brew, Australia
  • Kiren Naidoo, CEO of Zdravlje A.D. and Founder of Frontier Pharma, UK
  • Martin Mössler, Managing Director of Science Park Graz, Austria
  • Dr. Nataša Skoko, Head of Biotechnology Development Unit at International Centre for Genetic Engineering and Biotechnology, Italy

Business session: Accelerating innovation

Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University

  • Dan Vahdat, CEO of Huma, UK
  • Gloria Seibert, Founder & CEO at Temedica, Germany 
  • Dr. Milan Obradović, Senior Global Scientific Director Integrated Healthcare Solutions, Global Medical Affairs at Roche, Switzerland 
  • Dr. Ulrich A.K. Betz, Vice President Innovation in Merck, Germany
  • William Moss, CEO of Seven Bridges Genomics, USA

Back To Top